Fate Therapeutics Reports Fourth Quarter 2020 Financial Results and Highlights Operational Progress

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/24/2026

1. SPCX
2. SPY
3. META
4. ABBV
5. FDX
6. IBM
7. NKE
8. MU
9. PFE
10. AWK

Go back to Fate Therapeutics Reports Fourth Quarter 2020 Financial Results and Highlights Operational Progress

Fate Therapeutics (FATE) Misses Q4 EPS by 22c

February 24, 2021 4:37 PM EST

Fate Therapeutics (NASDAQ: FATE) reported Q4 EPS of ($0.61), $0.22 worse than the analyst estimate of ($0.39). Revenue for the quarter came in at $15.9 million versus the consensus estimate of $4.87 million.

For earnings history and earnings-related data on Fate Therapeutics (FATE) click here.

... More